Skip to content
Open access · CC-BY via OpenAlex

Urolithin A supplementation alleviates osteogenic disfunction and promotes bone fracture healing in inflammatory environments

Jinwu Bai, Jixing Fan, Ruideng Wang, Shilong Su, Daole Hu, Xi He, Shan Gao, Fang Zhou

Food & Nutrition Research · 2026 · ▲ 3 citations

Abstract

Excessive and chronic inflammation can cause osteogenic dysfunction and disrupt the balance of the osteoimmune microenvironment, thereby increasing the risk of fracture non-union. Urolithin A (UA), a gut microbiota-derived metabolite produced from dietary sources, has been reported to inhibit RANKL-induced osteoclastogenesis and alleviate postmenopausal osteoporosis. However, the effect of UA on osteogenesis, particularly under pathogenic inflammatory conditions, remains unclear. In this study, mouse bone marrow-derived mesenchymal stromal cells (mBMSCs) were used to evaluate osteogenesis in vitro, and RAW 264.7 cells were used as macrophages in vitro. Tumour necrosis factor (TNF)-α was used to establish an inflammatory environment. In vivo, a mouse femur fracture model with local TNF-α injection was established, and UA or vehicle was administered by intragastric gavage. The UA showed no obvious effect on cell viability at concentrations ranging from 0 to 10 μM and had no direct effect on the osteogenic differentiation of mBMSCs. TNF-α treatment significantly decreased the expression of osteogenesis-related genes and proteins and inhibited calcium deposition, whereas UA reversed this inhibitory effect in a dose-dependent manner. Mechanistically, UA inhibited activation of the TNF-α-induced nuclear factor-κB signalling pathway. Furthermore, UA reduced pro-inflammatory cytokine levels and inhibited type-1 macrophage polarisation under TNF-α-induced inflammatory conditions. Conditioned medium derived from RAW 264.7 cells stimulated with TNF-α after UA treatment promoted the osteogenic differentiation of mBMSCs. In vivo, local administration of TNF-α significantly impaired bone fracture healing in the mouse femur fracture model, whereas intragastric supplementation with UA improved fracture healing and reduced pro-inflammatory responses. Collectively, these findings demonstrated that UA alleviates osteogenic dysfunction through inhibition of the nuclear factor-κB signalling pathway and regulation of macrophage-mediated inflammation under TNF-α–induced inflammatory conditions, thereby promoting osteogenesis and fracture healing.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.29219/fnr.v70.13033
Canonical
link ↗
Fetched
2026-11-15 MST

Cite this

APA
Bai, J., Fan, J., Wang, R., Su, S., Hu, D., He, X., Gao, S., &amp; Zhou, F. (2026). Urolithin A supplementation alleviates osteogenic disfunction and promotes bone fracture healing in inflammatory environments. <em>Food & Nutrition Research</em>. https://doi.org/10.29219/fnr.v70.13033
Vancouver
Bai J, Fan J, Wang R, Su S, Hu D, He X, et al. Urolithin A supplementation alleviates osteogenic disfunction and promotes bone fracture healing in inflammatory environments. Food & Nutrition Research. 2026. doi:10.29219/fnr.v70.13033.
BibTeX
@article{jinwu2026Urolit, title = {Urolithin A supplementation alleviates osteogenic disfunction and promotes bone fracture healing in inflammatory environments}, author = {Jinwu Bai and Jixing Fan and Ruideng Wang and Shilong Su and Daole Hu and Xi He and Shan Gao and Fang Zhou}, journal = {Food & Nutrition Research}, year = {2026}, doi = {10.29219/fnr.v70.13033}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings